AMP heads into its July 22 earnings report having outrun most of its peers in recent weeks, yet with analysts still debating whether the stock has earned its valuation or run too far ahead of fundamentals.
The positioning picture is notably relaxed heading into the print. Options traders are skewing bullish — the put/call ratio of 0.308 is only modestly above its 20-day average of 0.282, placing it less than one standard deviation from normal, well off the defensive extremes the ratio has reached over the past year. The borrow market tells the same calm story. Borrow availability is exceptionally loose at 94 times the current short interest level, meaning there is no meaningful queue of bears pressing the name. Cost to borrow has ticked up around 65% on the week to 0.53% — still firmly in "cheap to short" territory and consistent with a stock where shorts are not under any squeeze pressure. Short interest has drifted lower too, down about 4% over the past month to 4.0% of the free float, as the stock climbed 12% over the same period. The stock pulled back 1% on July 17 to $527.87 after a 4.2% gain on the week, suggesting some pre-earnings caution crept in at the end of the session.
The analyst community moved decisively this past week, and the direction was unambiguously constructive. Multiple firms lifted price targets ahead of the release — Jefferies raised its Buy-rated target to $645, Evercore ISI pushed to $625, and Morgan Stanley raised its Underweight target to $489. The targets diverge sharply, and that gap captures the bull-bear split in one number. The bull case centers on Ameriprise's advice-centric model, which generates roughly 65% of operating income from wealth management, a business benefiting from continued advisor productivity growth and favorable migration toward fee-based accounts across a base of around 10,600 advisors. The bear case focuses on weaker asset management flow dynamics — slowing deposit growth paired with rising withdrawals — alongside a 3% quarter-on-quarter drop in brokerage cash balances to $36.9 billion that missed expectations last quarter. Morgan Stanley's Underweight remains the loudest dissent, with a target now at $489 against a current price of $527.87, implying meaningful downside from current levels. The consensus mean of $551 sits only 4.4% above the current price, suggesting the Street as a whole sees limited further runway unless the print surprises.
One institutional detail stands out from recent filings. BlackRock added 165,000 shares in the quarter ended June 30, bringing its position to 8.6 million shares — 9.6% of the company. State Street and Goldman Sachs Asset Management also added modestly in the same period, signalling that the largest passive and active holders are not reducing exposure into the event. Insider activity around the July 9 award cycle shows routine sell-to-cover patterns associated with equity grants rather than discretionary conviction sales, and the 90-day net value figure of $4.3 million reflects the CIO's larger May sale — nothing that changes the story.
Tuesday's print is less a test of whether Ameriprise's wealth management engine is working and more a test of whether the asset management segment's flow dynamics are stabilising, and whether brokerage cash balances have found a floor — the two metrics where the stock has most visibly underdelivered relative to expectations.
See the live data behind this article on ORTEX.
Open AMP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
